Page last updated: 2024-12-10

viqualine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID3050111
CHEMBL ID2104497
SCHEMBL ID141644
MeSH IDM0116857

Synonyms (18)

Synonym
viqualine
viqualine [inn]
4-[3-[(3r,4r)-3-ethenylpiperidin-4-yl]propyl]-6-methoxyquinoline
6-methoxy-4-(3-((3r,4r)-3-vinyl-4-piperidyl)propyl)quinoline
viqualinum [inn-latin]
unii-1y3a5e2l1j
viqualinum
viqualina [inn-spanish]
1y3a5e2l1j ,
72714-74-0
CHEMBL2104497
viqualine [mart.]
6-methoxy-4-(3-((3r,4r)-3-vinyl-4-piperidyl)propyl)quinoline.
SCHEMBL141644
(3r,4r)-4-[3-(6-methoxyquinolin-4-yl)propyl]-3-vinylpiperidine
XFXANHWIBFMEOY-JKSUJKDBSA-N
Q7933523
DTXSID601024516

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The mean apparent half-life was 12."( Pharmacokinetics and bioavailability of viqualine, a new antidepressant.
Bouquet, S; Courtois, P; Fourtillan, JB; Girault, J; Lefebvre, MA; Maulet, C,
)
0.4

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of oral viqualine averaged 80%."( Pharmacokinetics and bioavailability of viqualine, a new antidepressant.
Bouquet, S; Courtois, P; Fourtillan, JB; Girault, J; Lefebvre, MA; Maulet, C,
)
0.69

Dosage Studied

ExcerptRelevanceReference
" The subjects were randomly assigned to receive ethanol dosed to maintain blood alcohol concentrations of 17-22 mmol."( Kinetic and dynamic interactions of oral viqualine and ethanol in man.
Kadlec, KE; Kaplan, HL; Naranjo, CA; Sellers, EM; Shaw, CA; Sullivan, JT, 1989
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (42.86%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (42.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]